Personalizing Your Semaglutide Therapy With Genetic Insights The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Yu, H., Guo, P., Xie, X., Wang, Y
Patients should not take an extra dose or increase the next dose to make up for the missed one
Research shows that 3050% of people regain weight within one year of stopping GLP-1 therapy, but structured withdrawal combined with behavioral planning can significantly improve long-term outcomes
If you or a loved one experienced severe complications after taking a GLP-1 medication, speaking with a GLP-1 medication lawyer may help you better understand your legal rights and options